Track the Upstream Bio, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €375.2m. The latest transaction was reported on 17 June 2026 (Cession). Among the most active insiders: Ambrose Allison. All data is free.
16
Insider Decl.
n/a
Thresholds
€18m
1 ops.
Buy Volume
€40,726
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Upstream Bio, Inc. Buy (bullish), based on 8 analysts. Average price target: US$33.50.
48Σ signal
Buys €18m€40,726 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Upstream Bio, Inc. es una empresa que cotiza en el mercado XNAS, enfocada en el desarrollo de terapias biológicas innovadoras. Su objetivo es proporcionar soluciones para enfermedades inmunológicas e inflamatorias.